FindTrial
Sign In

Splicing factor SnRNP-E promotes breast cancer progression via regulating Mnk2 alternative splicing

Splicing factor SnRNP-E promotes breast cancer progression via regulating Mnk2 alternative splicing

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041747
Enrollment
Unknown
Registered
2021-01-04
Start date
2022-01-01
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

group according to molecular typing:Nil

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Women; (2) Stage I-III; (3) Aged 18-85 years; (4) Unilateral primary breast cancer; (5) After total mastectomy.

Exclusion criteria

Exclusion criteria: (1) The pathological type is simply carcinoma in situ; (2) Received anti-tumor treatment before surgery; (3) Suffer other malignant tumors.

Design outcomes

Primary

MeasureTime frame
Disease-free survival;—

Contacts

Public ContactYi-Zi Zheng

Shenzhen Second People's Hospital

zhengyz25@163.com+86 18823810015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026